AavantiBio is based in Cambridge. It has raised $107M in total funding. Latest round: Series A.
AavantiBio funding overview
AavantiBio is based in Cambridge. AavantiBio has raised $107M in total disclosed funding. That places its disclosed total in the $100M–$250M range. Its most recent disclosed round is a Series A announced in October 2020. The round record for AavantiBio runs through 2020; nothing later has been disclosed. Investors on record include Perceptive Advisors, Bain Capital Life Sciences, RA Capital Management, Sarepta Therapeutics, GoFAR, Muscular Dystrophy Association Venture Philanthropy Fund. 6 distinct backers are named across the disclosed rounds.
AavantiBio at a glance
Total raised
$107M
Latest round
Series A
Latest round date
October 2020
Headquarters
Cambridge
Notable investors
Perceptive Advisors, Bain Capital Life Sciences, RA Capital Management, Sarepta Therapeutics, GoFAR, Muscular Dystrophy Association Venture Philanthropy Fund
Frequently asked about AavantiBio funding
How much has AavantiBio raised?
AavantiBio has raised $107M in total disclosed funding across the rounds on record.
Who has invested in AavantiBio?
Perceptive Advisors, Bain Capital Life Sciences, RA Capital Management, Sarepta Therapeutics, GoFAR, Muscular Dystrophy Association Venture Philanthropy Fund are named among the investors backing AavantiBio.
What was the latest AavantiBio funding round?
The most recent disclosed round is a Series A, announced in October 2020.
Where is AavantiBio based?
AavantiBio is based in Cambridge.
When did AavantiBio last raise?
The last disclosed AavantiBio round closed in October 2020 at Series A.
We update the AavantiBio record whenever a new round is filed or announced, so the totals above track the public record rather than estimates. Related companies in Cambridge and their backers are listed below.
